Allergan Aesthetics, an AbbVie company, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). The recommendation supports approval of Boey (trenibotulinumtoxinE) in the European Union. Key regulatory milestone for Boey The decision marks a key regulatory milestone for the injectable treatment. It targets temporary improvement of moderate to severe glabellar lines ...